Rapport Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 135.7% | 135.7% | -22.4% |
| FY2024 | -25.6% | -25.6% | -24.9% |
| FY2025 | -23.0% | -23.0% | -21.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 135.7% | 135.7% | -22.4% |
| FY2024 | -25.6% | -25.6% | -24.9% |
| FY2025 | -23.0% | -23.0% | -21.8% |